Inhibitors of Nitric Oxide Synthase: What's up and What's Next?

Author(s): Lakshmikirupa Sundaresan, Suvendu Giri, Suvro Chatterjee

Journal Name: Current Enzyme Inhibition

Volume 12 , Issue 1 , 2016

Become EABM
Become Reviewer
Call for Editor


NO is a key signaling molecule that has a wide range of biological functions including vasodilation and neurotransmission, and is implicated in several pathological conditions. Therefore, modulation of NO is a desired step in curbing the NO-associated disease processes. Targetting NOS proteins and inhibiting their activity to reduce NO production is a major approach since the inception of NOS inhibitor research. Although a series of NOS inhibitors have been developed, synthesized and practiced in experimental biology, no NOS inhibitor has been approved as yet a drug for therapeutic uses. The present review elaborates the scope of the clinical uses of NOS inhibitors and the inherent limitations of the process that makes the approach less successful so far in clinic.

Keywords: Nitric Oxide (NO), Nitric Oxide Synthase (NOS), Nitric Oxide Synthase inhibitors, NOS oxidase domain, NOS reductase domain.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 03 March, 2016
Page: [81 - 107]
Pages: 27
DOI: 10.2174/1573408012666151126185922

Article Metrics

PDF: 54
PRC: 2